| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 1.30 | No resistance | Laboratory strain, Clinical Isolate | Details | Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing. (Sep 2021) | ||
| Maribavir | 0.40 | Possible hypersensitivity, no resistance | Laboratory strain, Clinical Isolate | Details | Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing. (Sep 2021) |